These results demonstrate that SLC7A5 mediates the influx of Met, which is converted to SAM to produce H3K4me3 at the IGF2BP2 promoter region, thus promoting IGF2BP2 expression in lung cancer cells. Here, IGF2BP2 is linked to lung carcinoma.